Health Insurance Innovations (NASDAQ:HIIQ) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $2.47-2.57 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.49. The company issued revenue guidance of $293-303 million, compared to the consensus revenue estimate of $294.67 million.
A number of research firms have recently weighed in on HIIQ. Canaccord Genuity reaffirmed a buy rating and issued a $62.00 price target (up from $55.00) on shares of Health Insurance Innovations in a research note on Thursday. ValuEngine raised shares of Health Insurance Innovations from a hold rating to a buy rating in a research note on Thursday. BidaskClub raised shares of Health Insurance Innovations from a buy rating to a strong-buy rating in a research note on Tuesday, June 5th. Zacks Investment Research raised shares of Health Insurance Innovations from a sell rating to a hold rating in a research note on Tuesday, June 5th. Finally, Cantor Fitzgerald reaffirmed a buy rating and issued a $60.00 price target on shares of Health Insurance Innovations in a research note on Monday. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of Buy and a consensus price target of $44.51.
Health Insurance Innovations stock traded up $6.10 during mid-day trading on Thursday, hitting $44.15. 1,167,600 shares of the company’s stock were exchanged, compared to its average volume of 372,203. The company has a market capitalization of $557.14 million, a price-to-earnings ratio of 36.79 and a beta of 0.47. Health Insurance Innovations has a 1-year low of $12.65 and a 1-year high of $44.40.
In other Health Insurance Innovations news, Director Anthony Barkett bought 3,597 shares of the stock in a transaction on Tuesday, May 8th. The shares were purchased at an average cost of $27.65 per share, with a total value of $99,457.05. Following the completion of the transaction, the director now directly owns 52,944 shares of the company’s stock, valued at approximately $1,463,901.60. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John Fichthorn sold 18,414 shares of the stock in a transaction on Friday, June 15th. The stock was sold at an average price of $34.98, for a total transaction of $644,121.72. Following the transaction, the director now directly owns 7,608 shares in the company, valued at $266,127.84. The disclosure for this sale can be found here. Insiders have acquired 19,759 shares of company stock worth $611,607 over the last three months. Company insiders own 55.94% of the company’s stock.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.
See Also: Leveraged Buyout (LBO)
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.